<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Annals of the Russian academy of medical sciences</journal-id><journal-title-group><journal-title xml:lang="en">Annals of the Russian academy of medical sciences</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник Российской академии медицинских наук</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-6047</issn><issn publication-format="electronic">2414-3545</issn><publisher><publisher-name xml:lang="en">"Paediatrician" Publishers LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">423</article-id><article-id pub-id-type="doi">10.15690/vramn.v69i5-6.1038</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>РATHOPHYSIOLOGY: CURRENT ISSUES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>АКТУАЛЬНЫЕ ВОПРОСЫ ПАТОФИЗИОЛОГИИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">IMMUNE DYSFUNCTION АND COGNITIVE DEFICIT IN STRESS AND PHYSIOLOGICAL AGING (PART I): PATHOGENESIS AND RISK FACTORS</article-title><trans-title-group xml:lang="ru"><trans-title>ИММУНОЛОГИЧЕСКИЕ НАРУШЕНИЯ И КОГНИТИВНЫЙ ДЕФИЦИТ ПРИ СТРЕССЕ И ФИЗИОЛОГИЧЕСКОМ СТАРЕНИИ. ЧАСТЬ I: ПАТОГЕНЕЗ И ФАКТОРЫ РИСКА</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pukhal'skii</surname><given-names>A. L.</given-names></name><name xml:lang="ru"><surname>Пухальский</surname><given-names>А. Л.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, professor, chief research scientist of the Department of Cystic Fibrosis of Research Centre of Medical Genetics (RCMG). Address: 1, Moskvorech’e Street, Moscow, RF, 115478.</p></bio><email>osugariver@yahoo.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Shmarina</surname><given-names>G. V.</given-names></name><name xml:lang="ru"><surname>Шмарина</surname><given-names>Г. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, leading research scientist of the Department of Cystic Fibrosis of<bold> </bold>Research Centre of Medical Genetics (RCMG)</p></bio><bio xml:lang="ru"><p>кандидат медицинских наук, ведущий научный сотрудник отдела муковисцидоза МГНЦ</p></bio><email>osugariver@yahoo.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Aleshkin</surname><given-names>V. A.</given-names></name><name xml:lang="ru"><surname>Алёшкин</surname><given-names>В. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD, professor, Director of G.N.Gabrichevskii Moscow Research Institute of Epidemiology and Microbiology</p></bio><bio xml:lang="ru"><p>доктор биологических наук, профессор, директор МНИИЭМ им. Г.Н. Габричевского</p></bio><email>info@gabrich.com</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Centre for Medical Genetics, Moscow, Russian Federation</institution></aff><aff><institution xml:lang="ru">Медико-генетический научный центр, Москва, Российская Федерация</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Research Centre for Medical Genetics, Moscow</institution></aff><aff><institution xml:lang="ru">Медико-генетический научный центр, Москва</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Gabrichevsky Institute of Epidemiology and Microbiology, Moscow</institution></aff><aff><institution xml:lang="ru">Московский НИИ эпидемиологии и микробиологии им. Г.Н. Габричевского</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2014-10-01" publication-format="electronic"><day>01</day><month>10</month><year>2014</year></pub-date><volume>69</volume><issue>5-6</issue><issue-title xml:lang="en">Vestnik Rossiiskoi akademii medetsinskikh nauk / Annals of the Russian academy of medical sciences</issue-title><issue-title xml:lang="ru">Вестник Российской академии медицинских наук</issue-title><fpage>14</fpage><lpage>22</lpage><history><date date-type="received" iso-8601-date="2015-08-07"><day>07</day><month>08</month><year>2015</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 1970, "Paediatrician" Publishers LLC</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 1970, Издательство "Педиатръ"</copyright-statement><copyright-year>1970</copyright-year><copyright-holder xml:lang="en">"Paediatrician" Publishers LLC</copyright-holder><copyright-holder xml:lang="ru">Издательство "Педиатръ"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://vestnikramn.spr-journal.ru/jour/about/submissions</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikramn.spr-journal.ru/jour/article/view/423">https://vestnikramn.spr-journal.ru/jour/article/view/423</self-uri><abstract xml:lang="en"><p><italic>The concept of stressful cognitive dysfunction, which is under consideration in this review, allows picking out several therapeutic targets.</italic><italic>The brain, immune and endocrine systems being the principal adaptive systems in the body permanently share information both in the form of neural</italic><italic> impulses and soluble mediators. The CNS differs from other organs due to several peculiarities that affect local immune surveillance. The brain cells</italic><italic> secluded from the blood flow by a specialized blood-brain-barrier (BBB) can endogenously express pro- and anti-inflammatory cytokines without</italic><italic>the intervention of the immune system. In normal brain the cytokine signaling rather contributes to exclusive brain function (e.g. long-term</italic><italic>potentiation, synaptic plasticity, adult neurogenesis) than serves as immune communicator. The stress of different origin increases the serum</italic><italic>cytokine levels and disrupts BBB. As a result peripheral cytokines penetrate into the brain where they begin to perform new functions. Mass intrusion</italic><italic>of biologically active peptides having a lot of specific targets alters the brain work that we can observe both in humans and in animal experiments.</italic><italic>In addition owing to BBB disruption dendritic cells and T cells also penetrate into the brain where they take up a perivascular position. The changes</italic><italic> observed in stressed subject may accumulate during repeated episodes of stress forming a picture typical of the aging brain. Moreover long-term</italic><italic> stress as well as physiological aging result in hormonal and immunological disturbances including hypothalamic-pituitary-adrenal axis depletion,</italic><italic> regulatory T-cell accumulation and dehydroepiandrosterone decrease.</italic></p></abstract><trans-abstract xml:lang="ru"><p><italic>В обзоре рассматриваются иммунологические механизмы развития когнитивного дефицита при стрессе и физиологическом старении,</italic><italic>а также предлагаются новые подходы к терапии подобных состояний. У млекопитающих сложный комплекс адаптационных механизмов представлен в виде триады, образованной центральной нервной, иммунной и эндокринной системой, которые постоянно обмениваются сигналами в виде нервных импульсов и растворимых медиаторов. Головной мозг, защищенный гематоэнцефалическим барьером (ГЭБ) от проникновения потенциально опасных клеток и растворимых факторов, самостоятельно продуцирует цитокины, которые вместе с другими нейромедиаторами регулируют процессы обучения и формирования памяти, а также нейрогенез у взрослых особей. Стресс любого происхождения сопровождается ростом концентрации цитокинов в крови и повышением проницаемости ГЭБ. В результате циркулирующие в крови цитокины могут проникать в мозг, где начинают выполнять «неиммунологические» функции. Ослабление барьерной функции ГЭБ и развивающаяся нейровоспалительная реакция способствуют массовой миграции дендритных клеток и лимфоцитов из периваскулярного пространства в паренхиму мозга. Вторжение чуждых центральной нервной системе медиаторов и иммунных клеток вызывает развитие когнитивных расстройств как у человека, так и у экспериментальных животных. Повторные эпизоды стресса способствуют накоплению в головном мозге иммунных клеток, обусловливают необратимое изменение проницаемости ГЭБ, нарушают нейрогенез у взрослых особей в зубчатой извилине гиппокампа. Подобные неблагоприятные изменения протекают в головном мозге пожилых людей при нормальном физиологическом старении. Более того, длительном стрессе и при физиологическом старении возникают сходные иммунологические и гормональные нарушения, прежде всего гиперактивация и последующее истощение гипоталамо-гипофизарно-надпочечниковой оси, накопление избыточного количества регуляторных Т клеток, снижение продукции дегидроэпиандростерона.</italic></p></trans-abstract><kwd-group xml:lang="en"><kwd>stress</kwd><kwd>cognitive dysfunction</kwd><kwd>hypothalamic-pituitary-adrenal axis</kwd><kwd>glucocorticoids</kwd><kwd>cytokines</kwd><kwd>dehydroepiandrosterone</kwd><kwd>regulatory T-cells</kwd><kwd>dehydroepiandrosterone</kwd><kwd>inflammation</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>стресс</kwd><kwd>когнитивный дефицит</kwd><kwd>гипоталамо-гипофизарно-надпочечниковая ось</kwd><kwd>глюкокортикоиды, цитокины</kwd><kwd>регуляторные Т клетки</kwd><kwd>дегидроэпиандростерон, воспаление</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1.	Maninger N., Wolokowitz O.M., Reus V.I. et al. Neurological and neuropsychiatric effects of dehydroepiandrosterone (DHEA) and DHEA sulfate (DHEAS). Front. Neuroendocrinoil. 2009;</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2.	: 65–91.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3.	Hazeldine J., Arlt W., Lord J.M. Dehydroepiandrosterone</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4.	as a regulator of immune cell function. J. Steroid Biochem. Mol. Biol. 2010; 120: 127–136.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5.	Goncharov N.P., Katsiya G.V. V kn.: Gormon zdorov'ya i dolgoletiya [In book Hormone of Health and Longevity]. Moscow, ADAMANT", 2012. 159 p.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6.	Chen J., Johnson R.W. Dehydroepiandrosterone-sulfate did not mitigate sickness behavior in mice. Physiol. Behav. 2004; 82: 713–719.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7.	Labrie F., Belanger A., Cusan L. et al. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab. 1997; 82: 2396–2402.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8.	Sulcova J., Hill M., Hampl R., Starka L. Age and sex related differences in serum levels of unconjugated dehydroepiandrosterone and its sulphate in normal subjects. J. Endocrinol. 1997; 154: 57–62.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9.	Pukhalsky A., Shmarina G., Alioshkin V. The Number of</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10.	Regulatory T Cells : Purs uit of the Golden Mean. In: Regulatory T Cells. R.S. Hayashi (ed.). Nova Science Publishers Inc. 2010. P. 261–268.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11.	Pukhal'skii A.L., Shmarina G.V., Aleshkin V.A. Vestnik RAMN = Annals of RAMS. 2011; 8: 24–33.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12.	Elenkov I.J., Iezzoni D.G., Daly A. et al. Cytokine disregulation, inflammation and well-being. Neuroimmunomodulation. 2005; 12: 255–269.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13.	Dhabhar F.S, Malarkey W.B., Neri E., McEwen B.S. Stress-induced redistribution of immune cells — from barracks to boulevards to battlefields: a tale of three hormones — Curt Richter Award winner. Psychoneuroendocrinology. 2012; 37: 1345–1368.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14.	Ziv Y., Ron N., Butovsky O. et al. Immunecells contribute to the maintenance of neurogenesis and spatial learning abilities in adulthood. Nat. Neurosci. 2006; 9: 268–275.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15.	Wolf S.A., Steiner B., Akpinarli A. et al. CD4-positive T</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16.	lymphocytes provide a neuroimmunological link in the control of adult hippocampal neurogenesis. J. Immunol. 2009; 182: 3979–3984.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17.	Wolf S.A., Steiner B., Wengner A. et al. Adaptive peripheral immune response increases proliferation of neural precursor cells in the adult hippocampus. FASEB J. 2009; 23: 3121–3128.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18.	Ron-Harel N., Cardon M., Schwartz M. Brain homeostasis is maintained by «danger» signals stimulating a supportive immune response within the brain’s borders. Brain Behav. Immun. 2011; 25: 1036–1043.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19.	Sorrells S.F., Caso J.R., Munhoz C.D., Sapolsky R.M. The stressed CNS: when glucocorticoids aggravate inflammation. Neuron. 2009; 64: 33–39.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20.	Yirmiya R., Goshen I. Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 2011; 25: 181–213.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21.	Yuen E.Y., Liu W., Karatsoreos I.N. et al. Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. Proc. Natl. Acad. Sci. USA. 2009; 106: 14075–14079.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22.	Garcia-Bueno B., Caso J.R., Leza J.C. Stress as a neuroinflammatory condition in brain: damaging and protective mechanisms. Neurosci. Biobehav. Rev. 2008; 32: 1136–1151.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23.	Mathieu P., Battista D., Depino A. et al. The more you</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>24.	have, the less you get: the functional role of inflammation on neuronal differentiation of endogenous and transplanted neural stem cells in the adult brain. J. Neurochem. 2010; 112: 1368–1385.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>25.	Finch C.E., Laping N.J., Morgan T.E. et al. TGF-beta 1 is an organizer of responses to neurodegeneration. J. Cell Biochem. 1993; 53: 314–322.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>26.	Nolan Y., Maher F.O., Martin D.S. et al. Role of interleukin-4 in regulation of age-related inflammatory changes in the hippocampus. Biol. Chem. 2005; 280: 9354–9362.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>27.	Negrini S., Fenoglio D., Balestra P. et al. Endocrine regulation of suppressor lymphocytes. Role of the glucocorticoids-induced TNF-like receptor. Ann. NY Acad. Sci. 2006; 1069: 377–385.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>28.	Wilkinson C.W., Petrie E.C., Murray S.R. et al. Human</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>29.	glucocorticoid feedback inhibition is reduced in older individuals: evening study. J. Clin. Endocrinol. Metab. 2001; 86: 545–550.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>30.	Heffner K.L. Neuroendocrine effects of stress on immunity in the elderly: implications for inflammatory disease. Immunol. Allergy Clin. North Am. 2011; 31: 95–108.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>31.	Bornstein S.R., Engeland W.C., Ehrhart-Bornstein M., Herman J.P. Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab. 2008; 19 (5): 175–180.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>32.	Butcher S.K., Lord J.M. Stress responses and innate immunity: aging as a contributory factor. Aging Cell. 2004; 3: 151–160.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>33.	Godbout J.P., Moreau M., Lestage J. et al. Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology. 2008; 33: 2341–2351.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>34.	Buchanan J.B., Sparkman N.L., Chen J., Johnson R.W. Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice. Psychoneuroendocrinology. 2008; 33: 755–765.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>35.	Bower J.E., Ganz P.A., Aziz N. Altered cortisol response to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom. Med. 2005; 67: 277–280.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>36.	Gaab, J., Baumann S., Budnoik A. et al. Reduced reactivity and enhanced negative feedback sensitivity of the hypothalamuspituitary- adrenal axis in chronic whiplash-associated disorder. Pain. 2005; 119: 219–224.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>37.	Weiner H.L. Induction and mechanism of action of transforming growth factor-β-secreting Th3 regulatory cells. Immunol. Rev. 2001; 182: 207–214.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>38.	Kipnis J., Schwartz M. Controlled autoimmunity in CNS</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>39.	maintenance and repair: naturally occurring CD4+CD25+</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>40.	regulatory T-Cells at the crossroads of health and disease.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>41.	Neuromolecular. Med. 2005; 7: 197–206.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>42.	Cohen H., Ziv Y., Cardon M. et al. Maladaptation to mental stress mitigated by the adaptive immune system via depletion of naturally occurring regulatory CD4+CD25+ cells. J. Neurobiol. 2006; 66: 552–563.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>43.	Pukhalsky A.L., Shmarina G.V., Alioshkin V.A., Sabelnikov A. HPA axis exhaustion and regulatory T cell accumulation in patients with a functional somatic syndrome: recent view on the problem of Gulf War veterans. J. Neuroimmunol. 2008; 196 (1–2): 133–138.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>44.	Wekerle H., Sun D.M. Fragile privileges: autoimmunity in brain and eye. Acta Pharmacol. Sin. 2010; 31: 1141–1148.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>45.	Neumann H., Boucraut J., Hahnel C. et al. Neuronal control of MHC class II inducibility in rat astrocytes and microglia. Eur. J. Neurosci. 1996; 8: 2582–2590.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>46.	Neumann H., Misgeld T., Matsumuro K., Wekerle H. Neurotrophins inhibit major histocompatibility class II inducibility of microglia: involvement of the p75 neurotrophin receptor. Proc. Natl. Acad. Sci. USA. 1998; 95: 5779–5784.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>47.	Spalding K.L., Bergmann O., Alkass K. et al. Dynamics of hippocampal neurogenesis in adult humans. Cell. 2013; 153 (6): 1219–1227.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>48.	Ziv Y., Schwartz M. Immune-based regulation of adult neurogenesis: implications for learning and memory. Brain Behav. Immun. 2008; 22: 167–176.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>49.	Pette M., Fujita K., Kitze B. et al. Myelin basic protein-specific T lymphocyte lines from MS patients and healthy individuals. Neurology. 1990; 40: 1770–1776.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>50.	Loewenbrueck K.F., Tigno-Aranjuez J.T., Boehm B.O. et al. Th1 responses to beta-amyloid in young humans convert to regulatory IL-10 responses in Down syndrome and Alzheimer’s disease. Neurobiol. Aging. 2010; 31: 1732–1742.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>51.	Derecki N.C., Privman E., Kipnis J. Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction? Mol. Psychiatry. 2010; 15: 355–363.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>52.	Palumbo M.L., Canzobre M.C., Pascuan C.G. et al. Stress induced cognitive deficit is differentially modulated in BALB/c and C57Bl/6 mice: correlation with Th1/Th2 balance after stress exposure. Neuroimmunology. 2010; 218: 12–20.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>53.	Miyazaki T., Ishikawa T., Nakata A. et al. Association between perceived social support and Th1 dominance. Biol. Psychol. 2005; 70: 30–37.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>54.	Suzuki T., Suzuki N., Engleman E.G. et al. Low serum levels of dehydroepiandrosterone may cause deficient IL-2 production by lymphocytes in patients with systemic lupus erythematosus (SLE). Clin. Exp. Immunol. 1995; 99: 251–255.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>55.	Setoguchi R., Hori,S., Takahashi T., Sakaguchi S. Homeostatic maintenance of natural Foxp3+ CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med. 2005; 201: 723–735.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>56.	Darrasse-Jeze G., Deroubaix S., Mouquet H. et al. Feedback control of regulatory T cell homeostasis by dendritic cells in vivo. J. Exp. Med. 2009; 206: 1853–1862.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>57.	Tesar B.M., Du W., Shirali A.C., Walker W.E. et al. Aging augments IL-17 T-cell alloimmune responses. Am. J. Transplant. 2008; 9: 54–63.</mixed-citation></ref><ref id="B58"><label>58.</label><mixed-citation>58.	Wuest T.Y., Willette-Brown J., Durum S.K., Hurwitz A.A. The influence of IL-2 family cytokines on activation and function of naturally occurring regulatory T cells. J. Leukoc. Biol. 2008; 84: 973–980.</mixed-citation></ref><ref id="B59"><label>59.</label><mixed-citation>59.	Godbout J.P., Moreau M., Lestage J. Aging exacerbates depressivelike behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology. 2008; 33: 2341–2351.</mixed-citation></ref><ref id="B60"><label>60.</label><mixed-citation>60.	Mooradian A.D. Effect of aging on the blood-brain barrier. Neurobiol Aging. 1988; 9: 31–39.</mixed-citation></ref><ref id="B61"><label>61.</label><mixed-citation>61.	Morita T., Mizutani Y., Sawada M., Shimada A. Immunohistochemical and ultrastructural findings related to the blood--brain barrier in the blood vessels of the cerebral white matter in aged dogs. J. Comp. Pathol. 2005; 133: 14–22.</mixed-citation></ref><ref id="B62"><label>62.</label><mixed-citation>62.	Stichel C.C., Luebbert H. Inflammatory processes in the aging mouse brain: participation of dendritic cells and T-cells. Neurobiol. Aging. 2007; 28: 1507–1521.</mixed-citation></ref><ref id="B63"><label>63.</label><mixed-citation>63.	Kaunzner U.W., Miller M.M., Gottfried-Blackmore A. et al. Accumulation of resident and peripheral dendritic cells in the aging CNS. Neurobiol. Aging. 2012; 33: 681–693.</mixed-citation></ref><ref id="B64"><label>64.</label><mixed-citation>64.	Pukhalsky A.L., Toptygina A.P. Genetic control of interleukin-2 production in inbred mice. Biull. Eksp. Biol. Med. 1989; 108 (9): 311–313.</mixed-citation></ref><ref id="B65"><label>65.</label><mixed-citation>65.	Yates J., Rovis F., Mitchell P. et al. The maintenance human CD4+CD25+ regulatory T cell function: IL-2, IL-4, IL-7 and IL-15 preserve optimal suppressive potency in vitro. Int. Immunol. 2007; 19: 785–799.</mixed-citation></ref><ref id="B66"><label>66.</label><mixed-citation>66.	Passerini L., Allan S.E., Battaglia M. et al. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4+CD25+ regulatory T cells and CD4+. Int. Immunol. 2008; 20: 421–</mixed-citation></ref><ref id="B67"><label>67.</label><mixed-citation>67.	Cohen A.C., Nadeau K.C., Tu W. et al. Cutting edge: decreased accumulation and regulatory function of CD4+ CD25(high) T cells in human STAT5b deficiency. J. Immunol. 2006; 177: 2770– 2774.</mixed-citation></ref><ref id="B68"><label>68.</label><mixed-citation>68.	Chen X., Oppenheim J.J., Howard O.M. BALB/c mice have more CD4+CD25+ T regulatory cells and show greater susceptibility to suppression of their CD4+CD25- responder T cells than C57BL/6 mice. J. Leukoc. Biol. 2005; 78: 114–121.</mixed-citation></ref><ref id="B69"><label>69.</label><mixed-citation>69.	Roque S., Nobrega C., Appelberg R., Correia-Neves M. IL-10 underlies distinct susceptibility of BALB/c and C57BL/6 mice to Mycobacterium avium infection and influences efficacy of antibiotic therapy. J. Immunol. 2007; 178: 8028–8035.</mixed-citation></ref><ref id="B70"><label>70.</label><mixed-citation>70.	Pukhalsky A., Shmarina G., Alioshkin V. The Number of Regulatory T Cells: Pursuit of the Golden Mean. In: Regulatory T Cells. Ren S. Hayashi (ed.). New York, Nova Science Publishers Inc., 2010. pp. 261–268.</mixed-citation></ref><ref id="B71"><label>71.</label><mixed-citation>71.	Tagawa N., Sugimoto Y., Yamada J., Kobayashi Y. Strain differences of neurosteroid levels in mouse brain. Steroids. 2006; 71: 776– 784.</mixed-citation></ref><ref id="B72"><label>72.</label><mixed-citation>72.	Xie T., Rowen L., Aguado B. et al. Analysis of the gene-dense major histocompatibility complex class III region and its comparison to mouse. Genome Res. 2003; 13: 2621–2636.</mixed-citation></ref><ref id="B73"><label>73.</label><mixed-citation>73.	Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF</mixed-citation></ref><ref id="B74"><label>74.</label><mixed-citation>74.	receptor superfamilies: integrating mammalian biology. Cell. 2001; 104: 487–501.</mixed-citation></ref><ref id="B75"><label>75.</label><mixed-citation>75.	Elewaut D., Ware C.F. The unconventional role of LT alpha beta in T cell differentiation. Trends Immunol 2007; 28: 169–175.</mixed-citation></ref><ref id="B76"><label>76.</label><mixed-citation>76.	Beste C., Baune B.T., Falkenstein M., Konrad C. Variations in the TNF-α gene (TNF-α -308G→A) affect attention and action selection mechanisms in a dissociated fashion. J. Neurophysiol. 2010; 104: 2523–2531.</mixed-citation></ref><ref id="B77"><label>77.</label><mixed-citation>77.	Beste C., Gunturkun O., Baune B.T. et al. Double dissociated effects of the functional TNF-α -308G/A polymorphism on processes of cognitive control. Neuropsychologia. 2011; 49: 196–202.</mixed-citation></ref><ref id="B78"><label>78.</label><mixed-citation>78.	Pukhalsky A.L., Shmarina G.V., Kapustin I.V. et al. Genetic heterogeneity of heat shock protein synthesis as a factor determining the resistance to stressors in mammalia. Cell &amp; Tissue Biol. 2011; 5 (1): 22–28.</mixed-citation></ref><ref id="B79"><label>79.</label><mixed-citation>79.	Pukhalsky A.L., Toptygina A.P., Viktorov V.V. Pharmacokinetics of alkylating metabolites of cyclophosphamide in different strains of mice. Int. J. Immunopharmacol. 1990; 12: 217–223.</mixed-citation></ref><ref id="B80"><label>80.</label><mixed-citation>80.	Zhang X., Beaulieu J.M., Sotnikova T.D. et al. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science. 2004; 305: 217.</mixed-citation></ref></ref-list></back></article>
